Combined N-of-1 Trials to Assess Open-Label Placebo Treatment for Antidepressant Discontinuation Symptoms

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 17, 2022

Primary Completion Date

February 21, 2024

Study Completion Date

May 15, 2024

Conditions
Depressive SymptomsExpectationsAntidepressants
Interventions
DRUG

Open-label placebo

Prior to the open-label placebo administration, an explanation why placebos without concealment might be effective is offered. Participants receive placebo pills with the instruction to take 2 pills daily for 2 weeks.

OTHER

No-treatment

During the no-treatment phase, participants receive no treatment for 2 weeks.

Trial Locations (2)

20251

University Medical Center Hamburg-Eppendorf, Hamburg

35037

Philipps University Marburg Medical Center, Marburg

All Listed Sponsors
collaborator

Philipps University Marburg

OTHER

collaborator

Helmut Schmidt University

OTHER

collaborator

University Hospital, Essen

OTHER

lead

Universitätsklinikum Hamburg-Eppendorf

OTHER